The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of prolapsed uterus and urinary incontinence.
It was reported that after implant, the patient experienced device failure, pain, bleeding, protrusion, fear of sexual intercourse, upset emotional distress, embarrassment, uterus again bulging, inability to lift or strain, recurrent urinary incontinence, recurrent prolapse, erosion, stage i breast cancer, hypertension, and vaginal pain.
Post-operative patient treatment included hysterectomy, device removal, and estrogen cream.
|